Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...
LGBTQ Nation on MSN
U.S. ships groundbreaking HIV drug to Africa, but slashed funding threatens progress
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
New diagnoses of HIV and syphilis have doubled in Florida since 2020. St. Lucie County has the highest rate of new HIV cases ...
Last year, 444 people in the Netherlands were diagnosed with HIV, the virus that can cause AIDS. Almost 20 years ago, there ...
The search for long-COVID treatments echoes the previous struggles against HIV/AIDS. Now researchers are taking lessons from ...
Activists have sharply criticised the US government’s move to exclude South Africa from receiving HIV prevention medication ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
To mark World AIDS Day, the Institute for Contemporary Arts will screen our film tackling the collapse of USAID funding ...
A new project co-led by Brown researchers is looking to tackle the recent rise in substance abuse, HIV, hepatitis C and ...
Zacks Investment Research on MSN
MRK HIV Regimen Meets Goal in New Study, Gains EU Nod for Keytruda SC
Merck MRK announced positive top-line results from a pivotal late-stage study evaluating its investigational, once-daily, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback